anmelden
25 € WM-Startbonus auf dein Cash-Konto
BX Swiss TOP 30 CHF
1.467,93
PKT
+14,91
PKT
+1,03
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 24.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 24.04.24 | Roche Hold | Jefferies & Company Inc. | |
| 24.04.24 | Roche Outperform | Bernstein Research | |
| 24.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.04.24 | UBS Outperform | RBC Capital Markets | |
| 23.04.24 | Novartis Underweight | Barclays Capital | |
| 23.04.24 | Novartis Buy | UBS AG | |
| 23.04.24 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 23.04.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 23.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 23.04.24 | UBS Underweight | Barclays Capital | |
| 22.04.24 | Richemont Buy | Goldman Sachs Group Inc. | |
| 19.04.24 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 19.04.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 19.04.24 | Zurich Insurance Overweight | Barclays Capital | |
| 19.04.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 18.04.24 | Roche Neutral | UBS AG | |
| 18.04.24 | Novartis Buy | UBS AG | |
| 18.04.24 | ABB (Asea Brown Boveri) Kaufen | DZ BANK | |
| 18.04.24 | Novartis Buy | Deutsche Bank AG | |
| 18.04.24 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 18.04.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 18.04.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 18.04.24 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 18.04.24 | Givaudan Neutral | UBS AG | |
| 17.04.24 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 17.04.24 | Zurich Insurance Overweight | Barclays Capital | |
| 16.04.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 16.04.24 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 15.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 15.04.24 | Zurich Insurance Hold | Deutsche Bank AG | |
| 15.04.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 15.04.24 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 12.04.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 12.04.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 12.04.24 | Givaudan Hold | Deutsche Bank AG | |
| 12.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 11.04.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 11.04.24 | UBS Overweight | JP Morgan Chase & Co. |